MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.
about
Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India.Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar.Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.
P2860
MDR-TB in Puducherry, India: reduction in attrition and turnaround time in the diagnosis and treatment pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MDR-TB in Puducherry, India: r ...... agnosis and treatment pathway.
@en
MDR-TB in Puducherry, India: r ...... agnosis and treatment pathway.
@nl
type
label
MDR-TB in Puducherry, India: r ...... agnosis and treatment pathway.
@en
MDR-TB in Puducherry, India: r ...... agnosis and treatment pathway.
@nl
prefLabel
MDR-TB in Puducherry, India: r ...... agnosis and treatment pathway.
@en
MDR-TB in Puducherry, India: r ...... agnosis and treatment pathway.
@nl
P2093
P2860
P356
P1433
P1476
MDR-TB in Puducherry, India: r ...... iagnosis and treatment pathway
@en
P2093
A M V Kumar
B N Sharath
C Palanivel
J P Tripathy
K Vivekananda
M Muthaiah
S Govindarajan
P2860
P304
P356
10.5588/PHA.16.0075
P577
2016-12-01T00:00:00Z